Investigation of prostaglandins for abortion.
D000028:Abortion, Induced / Q000379:methods*; D000293:Adolescent; D000328:Adult; D000650:Amnion; D005260:Female; D006801:Humans; D007267:Injections; D007273:Injections, Intramuscular; D010121:Oxytocin / Q000008:administration & dosage; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D011458:Prostaglandins E / Q000008:administration & dosage / Q000009:adverse effects; D011459:Prostaglandins E, Synthetic / Q000008:administration & dosage / Q000009:adverse effects; D011460:Prostaglandins F / Q000008:administration & dosage / Q000009:adverse effects; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage / Q000009:adverse effects; D013488:Suppositories; D014590:Uterine Contraction / Q000187:drug effects; D014621:Vagina
D011458:Prostaglandins E; D011459:Prostaglandins E, Synthetic; D011460:Prostaglandins F; D011461:Prostaglandins F, Synthetic; D013488:Suppositories; D010121:Oxytocin